The founder of Johnson Products Company, as he insists in his new memoir, “Afro Sheen: How I Revolutionized an Industry with ...
Johnson & Johnson (JNJ) begins on Tuesday its third attempt to push through a multi-billion-dollar settlement relating to ...
Healthcare conglomerate Johnson & Johnson kicked off its bankruptcy plan confirmation Tuesday, in its third attempt to ...
The 49-year-old legend scored a third-place finish in the Great American Race, his best showing since winning for the second ...
In a report released today, Matt Miksic from Barclays maintained a Hold rating on Johnson & Johnson (JNJ – Research Report), with a price ...
5dOpinion
The New Republic on MSNMike Johnson’s Disastrous Budget Bill Is Already in TroubleMike Johnson and House Republicans on Wednesday released their budget plan, which would raise the debt ceiling by $4 trillion ...
Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...
Our clients are passing away,” attorney James Onder told US Bankruptcy Judge Christopher Lopez on Tuesday, the start of a ...
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...
Johnson & Johnson begins a two-week trial on Feb. 18 over its plan to end tens of thousands of lawsuits filed by women or ...
Johnson & Johnson is considering selling its stroke care unit, Cerenovus, in a potential $1 billion deal as part of its ...
The January megadeals included transactions in the energy, financials, pharmaceuticals and materials sectors, signaling a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results